The effect of antiviral treatment on HBV-related HCC patients after curative therapy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PRCH-13003986

Enrollment

Unknown

Registered

2013-12-14

Start date

2007-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HBV-related HCC

Interventions

antiviral group:NAs

control group:no antiviral therapy

Eligibility

Sex/Gender

All

Age

39 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. HBV-related HCC; 2. after hepatic resection/ablation; 3. native antiviral patient.

Exclusion criteria

Exclusion criteria: 1. HCV/HIV coinfection; 2. HCC left; 3. treated with sorafenib.

Design outcomes

Primary

Measure	Time frame
recurrent rate;survival rate;	—

Secondary

Measure	Time frame
Child-Pugh grade;	—

Countries

China

Contacts

Public ContactWang Jiangbin

China-Japan Union hospital of Jilin University

zrlzhangqian@gmail.com+86 0431-84995780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026